PDF
Apotea AB (publ) ("Apotea") will publish its Q1 2025 report at 07:30 am CEST on Thursday the 8th of May. Investors, analysts, media and other interested parties are welcome to join a webcast and presentation of the interim report at 09:30 am the same day.
The results for the period January - March 2025 will be presented by Pär Svärdson, CEO, Sarah Ahnström, deputy CEO & COO, and Johan Mårild, CFO, via a webcast held on 8th of May 2025 at 09:30 am.
Link for webcast participation (no advance notification is necessary): https://apotea.events.inderes.com/q1-report-2025
If you wish to participate via teleconference, please register on the link below:
https://events.inderes.com/apotea/q1-report-2025/dial-in
The presentation will be held in English.
For further information, please contact:
Stefan Eriksson, deputy CEO & Investor Relations
E-mail: [email protected]
About Apotea
Apotea is Sweden's leading online pharmacy by market share with the goal of becoming the largest pharmacy in Sweden and hence also in the Nordics. With the widest assortment on the market, low prices and quick deliveries, Apotea facilitates everyday life for its three million active customers. In E-barometern's 2024 customer survey, Apotea was ranked as customers' favourite e-commerce store for the seventh consecutive year. Since 2022, the group also operates in Norway through its Norwegian subsidiary Apotera.